glp-1 for insulin resistance GLP-1a: Going beyond Traditional Use Schematic of action of GLP-1

If your BMI is 35+ and you need significant reduction, tirzepatide is the stronger tool

The GLP-1s are really intriguing for people who mostly struggle with loss-of-control eating, says Joanna Steinglass, director of research at the Eating Disorders Research Clinic at Columbia University

Expect to see oral doses in the hundreds of milligrams to achieve what injectable doses accomplish in single-digit milligrams

Cardiovasc Res 2004;61:297306.PubMed 81

AstraZeneca plc (UK) Established in 1999, AstraZeneca has played an important role in expanding treatment options in type 2 diabetes through its work in GLP-1 and related metabolic pathways